| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ifosfamide | CTRPv2 | pan-cancer | AAC | -0.052 | 0.3 |
| mRNA | momelotinib | CTRPv2 | pan-cancer | AAC | -0.034 | 0.3 |
| mRNA | BRD-K11533227 | CTRPv2 | pan-cancer | AAC | 0.036 | 0.3 |
| mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | -0.036 | 0.3 |
| mRNA | BRD-K50799972 | CTRPv2 | pan-cancer | AAC | 0.037 | 0.3 |
| mRNA | I-BET151 | CTRPv2 | pan-cancer | AAC | 0.03 | 0.3 |
| mRNA | manumycin A | CTRPv2 | pan-cancer | AAC | 0.031 | 0.3 |
| mRNA | hyperforin | CTRPv2 | pan-cancer | AAC | 0.038 | 0.3 |
| mRNA | dabrafenib | CTRPv2 | pan-cancer | AAC | 0.045 | 0.3 |
| mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | -0.03 | 0.3 |